SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-18-008905
Filing Date
2018-11-08
Accepted
2018-11-08 08:40:30
Documents
50
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q zyne-20180930x10q.htm 10-Q 944582
2 EX-31.1 zyne-20180930ex3113f5d24.htm EX-31.1 13580
3 EX-31.2 zyne-20180930ex312c1b721.htm EX-31.2 13369
4 EX-32.1 zyne-20180930ex321b8b198.htm EX-32.1 6162
5 EX-32.2 zyne-20180930ex3228589f4.htm EX-32.2 6173
6 GRAPHIC zyne20180930x10q001.jpg GRAPHIC 60719
  Complete submission text file 0001558370-18-008905.txt   3940486

Data Files

Seq Description Document Type Size
7 EX-101.INS zyne-20180930.xml EX-101.INS 830011
8 EX-101.SCH zyne-20180930.xsd EX-101.SCH 25841
9 EX-101.CAL zyne-20180930_cal.xml EX-101.CAL 30392
10 EX-101.DEF zyne-20180930_def.xml EX-101.DEF 112593
11 EX-101.LAB zyne-20180930_lab.xml EX-101.LAB 246568
12 EX-101.PRE zyne-20180930_pre.xml EX-101.PRE 212547
Mailing Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333
Business Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333 484-581-7505
Zynerba Pharmaceuticals, Inc. (Filer) CIK: 0001621443 (see all company filings)

IRS No.: 260389433 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37526 | Film No.: 181168321
SIC: 2834 Pharmaceutical Preparations